This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): Casopitant mesylate, GW679769, Zunrisa
Description: Casopitant, an NK-1 antagonist, is an anti-emetic medicine. The neurokinin receptors (NK-1R, NK-2R, and NK-3R) are receptors for are a family of neuropeptides called tachykinins.
Pink Sheet GSK calls it quits on casopitant
Additional information available to subscribers only: